Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by YUANQING YE and MICHELLE A.T. HILDEBRANDT.
YUANQING YE
Connection Strength
1.658
MICHELLE A.T. HILDEBRANDT
  1. Patterns of racial/ethnic disparities in baseline health-related quality of life and relationship with overall survival in patients with colorectal cancer. Qual Life Res. 2020 Nov; 29(11):2977-2986.
    View in: PubMed
    Score: 0.185
  2. Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients. Sci Rep. 2018 Jul 13; 8(1):10640.
    View in: PubMed
    Score: 0.161
  3. Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosis. Qual Life Res. 2017 02; 26(2):319-330.
    View in: PubMed
    Score: 0.141
  4. Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. Sci Rep. 2015 Jul 13; 5:12068.
    View in: PubMed
    Score: 0.131
  5. Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients. Carcinogenesis. 2012 Apr; 33(4):799-803.
    View in: PubMed
    Score: 0.103
  6. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One. 2010 Aug 25; 5(8):e12402.
    View in: PubMed
    Score: 0.093
  7. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene. 2010 Oct 21; 29(42):5724-8.
    View in: PubMed
    Score: 0.093
  8. A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. HGG Adv. 2022 Jan 13; 3(1):100078.
    View in: PubMed
    Score: 0.051
  9. Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma. Eur J Cancer. 2018 03; 92:20-32.
    View in: PubMed
    Score: 0.039
  10. Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data. J Natl Cancer Inst. 2017 07 01; 109(7).
    View in: PubMed
    Score: 0.038
  11. Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer. 2017 Oct 15; 123(20):4066-4074.
    View in: PubMed
    Score: 0.037
  12. The somatic mutation landscape of premalignant colorectal adenoma. Gut. 2018 07; 67(7):1299-1305.
    View in: PubMed
    Score: 0.037
  13. Genetic Variants in the Wnt/?-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk. J Urol. 2015 Dec; 194(6):1771-6.
    View in: PubMed
    Score: 0.033
  14. Identification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted Metabolic Profiling. Clin Gastroenterol Hepatol. 2015 Oct; 13(10):1730-1737.e9.
    View in: PubMed
    Score: 0.032
  15. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis. 2015 Feb; 36(2):243-8.
    View in: PubMed
    Score: 0.031
  16. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clin Cancer Res. 2015 Jan 01; 21(1):193-200.
    View in: PubMed
    Score: 0.031
  17. Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer. Clin Pharmacol Ther. 2014 Nov; 96(5):609-15.
    View in: PubMed
    Score: 0.031
  18. Joint association of genome-wide association study-identified susceptibility loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites. Am J Epidemiol. 2014 Sep 01; 180(5):499-507.
    View in: PubMed
    Score: 0.031
  19. Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. Clin Pharmacol Ther. 2014 Sep; 96(3):360-369.
    View in: PubMed
    Score: 0.030
  20. Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res. 2013 Aug 01; 73(15):4801-9.
    View in: PubMed
    Score: 0.028
  21. Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers. Cancer Res. 2013 Jul 01; 73(13):4028-38.
    View in: PubMed
    Score: 0.028
  22. MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients. Cancer Res. 2013 Mar 15; 73(6):1867-75.
    View in: PubMed
    Score: 0.028
  23. Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer. Carcinogenesis. 2013 May; 34(5):1006-11.
    View in: PubMed
    Score: 0.028
  24. Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clin Cancer Res. 2012 Nov 01; 18(21):5983-91.
    View in: PubMed
    Score: 0.027
  25. Variations in the vascular endothelial growth factor pathway predict pulmonary complications. Ann Thorac Surg. 2012 Oct; 94(4):1079-84; discussion 1084-5.
    View in: PubMed
    Score: 0.027
  26. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet. 2012 Jan 15; 21(2):456-62.
    View in: PubMed
    Score: 0.025
  27. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst. 2011 May 18; 103(10):817-25.
    View in: PubMed
    Score: 0.024
  28. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. Cancer Prev Res (Phila). 2011 Feb; 4(2):185-93.
    View in: PubMed
    Score: 0.024
  29. A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity. Hum Mol Genet. 2011 Feb 15; 20(4):820-6.
    View in: PubMed
    Score: 0.024
  30. PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. Lung Cancer. 2011 Jan; 71(1):82-8.
    View in: PubMed
    Score: 0.023
  31. Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog. 2010 Feb; 49(2):183-9.
    View in: PubMed
    Score: 0.022
  32. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis. 2009 Dec; 30(12):2047-52.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.